Soft tissue infections related to peripheral intravenous catheters in hospitalised patients: A case-control study

Journal of Hospital Infection

Volumn 76, Issue 2, 2010, Pages 124-129

  Lee, W L ^a,b   Liao, S F ^b   Lee, W C ^b   Huang, C H ^a,c   Fang, C T ^b,d  

^a CATHAY GENERAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Catheter related soft tissue infection; Nosocomial infection; Peripheral intravenous catheter; Risk factors; Surveillance

Indexed keywords

ANTIBIOTIC AGENT;

ABSCESS; ABSCESS DRAINAGE; ADULT; AGED; ARTICLE; BACTEREMIA; BLOOD CULTURE; CASE CONTROL STUDY; CATHETER INFECTION; CELLULITIS; CHRYSEOBACTERIUM INDOLOGENES; CLINICAL ARTICLE; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTINUOUS INFUSION; CONTROLLED STUDY; DEBRIDEMENT; DISEASE ASSOCIATION; ESCHERICHIA COLI; FEMALE; FLUID RESUSCITATION; HOSPITAL PATIENT; HUMAN; INFECTION RISK; INFUSION PUMP; INTRAVENOUS CATHETER; KLEBSIELLA PNEUMONIAE; MALE; NEUROLOGIC DISEASE; NEUROSURGERY; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK REDUCTION; SOFT TISSUE INFECTION; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS MITIS; TREATMENT DURATION; UNIVERSITY HOSPITAL;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CATHETER-RELATED INFECTIONS; CATHETERIZATION, PERIPHERAL; CATHETERS, INDWELLING; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SOFT TISSUE INFECTIONS;

EID: 77956179923     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2010.05.012     Document Type: Article

References (24)

1. Kagel E.M., Rayan G.M. Intravenous catheter complications in the hand and forearm. J Trauma 2004, 56:123-127.
2. Pratt R.J., Pellowe C.M., Wilson J.A., et al. Epic2: national evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England. J Hosp Infect 2007, 65S:S1-64.
3. Rello J., Ochagavia A., Sabanes E., et al. Evaluation of outcome of intravenous catheter-related infections in critically ill patients. Am J Respir Crit Care Med 2000, 162:1027-1030.
4. Dimick J.B., Pelz R.K., Consunji R., Swoboda S.M., Hendrix C.W., Lipsett P.A. Increased resource use associated with catheter-related bloodstream infection in the surgical intensive care unit. Arch Surg 2001, 136:229-234.
5. O'Grady N.P., Alexander M., Dellinger E.P., et al. Guidelines for the prevention of intravascular catheter-related infections. Morb Mortal Wkly Rep 2002, 51(RR-10):1-26.
6. Hoffmann K.K., Weber D.J., Samsa G.P., Rutala W.A. Transparent polyurethane film as an intravenous catheter dressing, a meta-analysis of the infection risks. J Am Med Assoc 1992, 267:2072-2076.
7. Garner J.S., Jarvis W.R., Emori T.G., Horan T.C., Hughes J.M. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988, 16:28-40.
8. Coughlin S.S., Benichou J., Weed D.L. Attributable risk estimation in case-control studies. Epidemiol Rev 1994, 16:51-64.
9. Rothman K.J. Cause. Am J Epidemiol 1976, 104:587-592.
10. Maki D.G., Ringer M., Alvarado C.J. Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet 1991, 338:339-343.
11. Darouiche R.O., Wall M.J., Itani K.M., et al. Chlorhexidine-alcohol versus povidone-iodine for surgical-site antisepsis. N Engl J Med 2010, 362:18-26.
12. Soifer N.E., Borzak S., Edlin B.R., Weinstein R.A. Prevention of peripheral venous catheter complications with an intravenous therapy team: a randomized controlled trial. Arch Intern Med 1998, 158:473-477.
13. Palefski S.S., Stoddard G.J. The infusion nurse and patient complication rates of peripheral-short catheters. J Intraven Nurs 2001, 24:113-123.
14. Lee W.L., Chen H.L., Tsai T.Y., et al. Risk factors for peripheral intravenous catheter infection in hospitalized patients: a prospective study of 3165 patients. Am J Infect Control 2009, 37:683-686.
15. Maki D.G., Botticelli J.T., LeRoy M.L., Thielke T.S. Prospective study of replacing administration sets for intravenous therapy at 48-vs 72-hour intervals, 72 hours is safe and cost-effective. J Am Med Assoc 1987, 258:1777-1781.
16. Macias A.E., de Leon S.P., Huertas M., et al. Endemic infusate contamination and related bacteremia. Am J Infect Control 2008, 36:48-53.
17. Playford E.G., Looke D.F.M., Whitby M., Stackelroth J., Harrison K., Watts A. Endemic nosocomial Gram-negative bacteraemias resulting from contamination of intravenous heparin infusions. J Hosp Infect 1999, 42:21-26.
18. Mermei L.A. Bacteriology, safety and prevention of infection associated with continuous intravenous infusions. Blood Coagul Fibrinolysis 1996, 7:S45-51.
19. Pittet D. Nosocomial bloodstream infections. Prevention and control of nosocomial infections 2005, 740-747. Williams & Wilkins, Baltimore. 3rd ed. R.P. Wenzel (Ed.).
20. Waitt C., Waitt P., Pirmohamed M. Intravenous therapy. Postgrad Med J 2004, 80:1-6.
21. Indar R. The dangers of indwelling polyethylene cannulae in deep veins. Lancet 1959, 1:284-286.
22. Crane C. Venous interruption of septic thrombophlebitis. N Engl J Med 1960, 262:947-951.
23. Brown S.L., Morrison A.E. Local anesthetic infusion pump systems adverse events reported to the Food and Drug Administration. Anesthesiology 2004, 100:1305-1306.
24. Curran E.T., Coia J.E., Gilmour H., McNamee S., Hood J. Multi-centre research surveillance project to reduce infections/phlebitis associated with peripheral vascular catheters. J Hosp Infect 2000, 46:194-202.